https://www.marketscreener.com/quote/stock/DIAMEDICA-INC-6501136/news/DiaMedica-Announces-First-Enrollment-in-its-PHASE-2-REMEDY-TRIAL-for-Acute-Ischemic-Stroke-26036051/?utm_source=telegram&utm_medium=social&utm_campaign=share